Product Information
MOTPOLY XR 200 MG CAPSULE is a brand product labeled by Aucta Pharmaceuticals, Inc., priced at $21.3032 per EA under NDC 73289006502. Its NADAC has been published 71 times since Feb 19, 2025.
The High Outlier badge above means this manufacturer's average price in the lacosamide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/1
Manufacturer
Aucta Pharmaceuticals, Inc.NDC
73289006502
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LACOSAMIDEApproval Type
New Drug (NDA)
FDA Application
NDA216185On Market Since
5/5/2023
Pharmacological Classes
Price Statistics
The NADAC for MOTPOLY XR 200 MG CAPSULE has been published 71 times since Feb 19, 2025, and over the history we have for it it has risen 4.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $21.3032 per EA |
|---|---|
| All-time high | $21.3097 (Jun 10, 2026) |
| All-time low | $20.3439 (Jun 18, 2025) |
| 52-week high | $21.3097 |
| 52-week low | $20.3439 |
| Median price | $20.6470 |
| Average price | $20.7777 |
| Largest weekly change | +3.0% (Jan 14, 2026) |
| Weeks tracked | 71 |
| Tracking since | Feb 19, 2025 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MOTPOLY XR 200 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MOTPOLY XR 200 MG CAPSULE, manufactured by Aucta Pharmaceuticals, Inc., is $21.3032 per EA (NDC 73289006502), effective Jun 24, 2026.
How has the price of MOTPOLY XR 200 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MOTPOLY XR 200 MG CAPSULE has risen 4.5%. It has been tracked across 71 weekly CMS publications since Feb 19, 2025.
What are the highest and lowest recorded NADAC prices for MOTPOLY XR 200 MG CAPSULE?
Since Feb 19, 2025, the NADAC for MOTPOLY XR 200 MG CAPSULE has ranged from a low of $20.3439 (Jun 18, 2025) to a high of $21.3097 (Jun 10, 2026), with a median of $20.6470 per EA.
Are there cheaper alternatives to MOTPOLY XR 200 MG CAPSULE?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LACOSAMIDE 200 MG TABLET, is $0.2767 per EA — about 99% below MOTPOLY XR 200 MG CAPSULE.
Who manufactures MOTPOLY XR 200 MG CAPSULE?
MOTPOLY XR 200 MG CAPSULE (NDC 73289006502) is labeled by Aucta Pharmaceuticals, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification